ATTAIN-CN

A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

OrforglipronOngoingNot yet recruitingPhase 3Open NCT07790861 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

ATTAIN-CN · Trial Tracker · ComplyRx